Chemoinformaics analysis of 1,3,4-tri-o-galloyl-beta-d-glucose
| Molecular Weight | 636.471 | nRot | 7 |
| Heavy Atom Molecular Weight | 612.279 | nRig | 27 |
| Exact Molecular Weight | 636.096 | nRing | 4 |
| Solubility: LogS | -2.368 | nHRing | 1 |
| Solubility: LogP | 1.131 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 3 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 18 |
| nHA | 18 | APOL | 75.529 |
| nHD | 11 | BPOL | 33.625 |
| QED | 0.09 |
| Synth | 4.327 |
| Natural Product Likeliness | 1.076 |
| NR-PPAR-gamma | 0.521 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.07 |
| Pgp-sub | 0.006 |
| HIA | 0.965 |
| CACO-2 | -6.96 |
| MDCK | 0.0000162 |
| BBB | 0.019 |
| PPB | 0.856018 |
| VDSS | 0.503 |
| FU | 0.191847 |
| CYP1A2-inh | 0.527 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.024 |
| CYP2c9-inh | 0.44 |
| CYP2c9-sub | 0.038 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.09 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.002 |
| CL | 9.065 |
| T12 | 0.967 |
| hERG | 0.3 |
| Ames | 0.083 |
| ROA | 0 |
| SkinSen | 0.966 |
| Carcinogencity | 0.01 |
| EI | 0.92 |
| Respiratory | 0.006 |
| NR-Aromatase | 0.482 |
| Antiviral | Yes |
| Prediction | 0.737167 |